George Zorich
CEO and Chairman of Nevakar, Inc. (Nevakar Injectables and Vyluma)
Lake Forest, Illinois, United States
*50 free lookup(s) per month.
No credit card required.
George Zorich’s Email george.zorich@zedpharma.com
George Zorich’s Phone Numbers No Phone Number Available
Social Media
George Zorich’s Location Lake Forest, Illinois, United States
George Zorich’s Current Industry Nevakar Inc. Nevakar Injectables, Inc. ZEDpharma, Inc.
George Zorich’s Prior Industry Custopharm, Inc. (Acquired by Hikma in 2022) | Agilis Biotherapeutics, (acquired by PTC Therapeutics, Inc.) | Bioniche Pharmaceuticals, (acquired by Mylan for $550 Million) | Sabex Pharmaceuticals (acquired by Sandoz for $480 Million) | General Injectables and Vaccines (GIV) - acquired by Henry Schein | Fujisawa Pharmaceuticals (now Astellas Pharma US) | Roxane Laboratories, a Division of Boehringer Ingelheim | Eli Lilly and Company
Not the George Zorich you were looking for?
Find accurate emails & phone numbers for over 700M professionals.
Work Experience
Nevakar Inc.
CEO and Chairman of the Board
2024-02-01 - PresentNevakar Injectables, Inc.
Board Member
2021-04-01 - PresentZEDpharma, Inc.
Chief Executive Officer
2015-01-01 - PresentCustopharm, Inc. (Acquired by Hikma in 2022)
Board Member
2015-01-01 - 2022-04-01Agilis Biotherapeutics, (acquired by PTC Therapeutics, Inc.)
Chief Executive Officer
2014-01-01 - 2014-12-01Bioniche Pharmaceuticals, (acquired by Mylan for $550 Million)
President
2005-01-01 - 2011-01-01Sabex Pharmaceuticals (acquired by Sandoz for $480 Million)
President
2002-01-01 - 2005-10-01General Injectables and Vaccines (GIV) - acquired by Henry Schein
President
1997-01-01 - 2000-12-01Fujisawa Pharmaceuticals (now Astellas Pharma US)
Head of Business Development
1990-06-01 - 1996-12-01Roxane Laboratories, a Division of Boehringer Ingelheim
Director of Marketing
1987-01-01 - 1990-05-01Eli Lilly and Company
Sales and Marketing Positions including home office
1979-06-01 - 1986-12-01